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Abstract
   We tested hexane, methanol and 50% aqueous acetone extracts of kaki calyx for their inhibitory 
activity on recombinant hepatitis C virus NS3/4A protease. The 50 % aqueous acetone extract had the 
highest inhibitory activity, and was fractioned by Sephadex LH20 column chromatography. The 70 % 
methanol fraction of the column chromatography was further fractioned by silica gel column/thin layer 
chromatography, and triterpenes, betulinic acid, oleanolic acid, and ursolic acid, were isolated. They were 
identified by analyses using HPLC equipped with a polycyclic aromatic hydrocarbons (PAH) column and 
1H-NMR spectroscopy. The triterpenes were thought to be the main inhibitory compounds in the 50 % 
aqueous acetone extract of kaki calyx, but there may be inhibitory compounds other than the 
triterpenes.  
Key words ：HCV, NS3/4A protease, inhibitor, Kaki calix, triterpene
School of Pharmaceutical Sciences, Kyushu University of Health and Welfare; 
1714-1 Yoshino-cho, Nobeoka city, Miyazaki, 882-8508, Japan. 
Introduction
  Hepatitis C virus (HCV) is a major cause of acute and 
chronic human hepatitis. Approximately, 3 % of the 
population (180 million people worldwide) is infected 
with HCV 1. Despite of successful anti-HCV therapies 
developed recent years, many patients with HCV in 
the world are anticipated alternative treatments that 
are easier to access and low in cost are needed. 
Traditional medicines from various areas in the world 
are hopeful candidate for developing novel HCV 
drugs2. We reported the anti-HCV protease activity of 
extracts from the peel and seeds of a tropical fruit in 
Peru, and included tannic conpounds 3. Furthermore, 
methanol extracts of 13 crude drugs were tested for 
inhibitory activity on the enzyme reaction, and 6 of 
them at a concentration of 100 µg/ml inhibited the 
reaction more than 90%. Five of these effective 
extracts contained as much as 800-1500 µg/ml 
phenolics, but the extract of kaki (persimmon) calyx 
contained less than 400 µg/ml4. Here, we focus on 
inhibitory principle of kaki calyx other than phenolics.
Materials and methods
Chemicals
  Oleanolic acid and betulinic acid were purchased 
from Aldrich (USA and UK), and ursolic acid from 
Tocris (UK). The protease substrate having a 13-amino 
ac id sequence o f HCV NS5A- NS5B junct i on 
(DDIVPCSMSYTWT) and a peptide, P41, consist of the 
sequence of 20 N-terminal amino acids of HCV NS4A 
were purchased from BioSynthesis Inc., (USA) or GL 
Biochem (China). The purities of these peptides were 
greater than 85 %. Analytical (1.05715.0001) and 
preparative (1.13895.0001) silica gel 60 F254 thin layer 
plates were obtained from Merck Millipore (USA). 
Herbal material and extract producing
  Kaki calyxes (Lot 023415001) were obtained from 
Uchida Wakanyaku Ltd. (Japan), and were powdered 
after breaking into small pieces. Fifty grams of the 
crude drug powder was suspended in 200 ml of hexane 
and extracted under sonication for 30 min. The hexane 
layer was removed, and the remaining solid was dried. 
Two hundred milliliters of 50 % acetone aqueous 
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solution or methanol was added to the solid and 
sonicated for 30min, and the liquid layer was removed. 
The extraction with 50 % acetone aqueous solution or 
methanol was repeated 3 times. After filtration, the 
extracts were evaporated to remove solvent and 
weighed. 
Fractionation of the 50 % acetone aqueous solution 
extract of Kaki calyx
  The 50 % acetone aqueous extract of Kaki calyx was 
dissolved in 50 % methanol, and was applied to a 
column of Sephadex LH20 swelled in 50 % methanol. 
The column was eluted with methanol-water mixtures 
in a stepwise manner of 50 %, 60 %, 70% and 100 % 
methanol, and then eluted with 50 % aqueous acetone 
solution. Each fraction was evaporated to remove 
solvent and weighed. 
Recombinant HCV protease (∆NS3) preparation and 
enzyme reaction.
  Expression of a plasmid containing amino acid 
sequence of HCV polypeptide from 1027 to 1218 and 
six histidine residues in series at N-terminal adjoining 
region to the HCV peptide in Escherichia coli JM109 
was performed according to the method reported 
previously 5. Purification of the expressed peptide 
using Ni-NTA Quick Start Kit (QIAGEN, Germany) 
was carried out according to the manufacture’s 
protocol. The recombinant enzyme together with the 
HCV NS4 peptide P41 hovering amino acid 1673-1692, 
which was found to participate in proteolytic reaction, 
were reacted with a synthetic peptide (DDIVPC / 
SMSYTWT) corresponding the cleavage site of HCV 
NS5A/5B 6. HPLC analysis for enzyme reaction was 
performed using the Shimadzu liquid chromatography 
system 4. Inhibition (%) was calculated based on the 
HPLC peak area of the remaining substrate of the 
reaction (Rn), that of positive control (PC), the reaction 
carried out without sample, and the negative control 
(NC), the reaction without enzyme and sample, as the 
following: Inhibition (%) = 100 x (Rn-PC)/(NC-PC)
HPLC analysis of triterpenes
  The HPLC analysis was performed on the Shimadzu 
liquid chromatography system (LC-10ADvp Pumping 
Unit , DGU-14AM degasser , SPD-10A UV–VIS 
u l trav io le t detector , CTO-10ACco lumn oven , 
Chromatopac C-R8A data processor, and SLC-10A 
System Controller) equipped with a Zorbax Eclipse 
PAH column 250-4.6 (5 µm) (Agilent Technologies). The 
column was eluted with an acetonitrile-water mixture 
of 85 % acetonitrile at 30 ° C, and the UV signal at 
215 nm was monitored. 
Results and Discussion
Inhibitory activity of extracts and fractions of kaki 
calyx
  Hexane, methanol, and 50 % aqueous acetone extracts 
of kaki calyx were tested for their inhibitory activity 
on recombinant HCV NS3/4A protease. As shown in 
Fig 1, the 50 % aqueous acetone extract was found to 
have the highest activity as well as the highest yield. 
The extract was fractionated by Sephadex LH20 
column chromatography. The fraction eluted with 50 % 
methanol exhibited less inhibitory activity than the 
starting extract, and higher activity was observed in 
fractions eluted with higher methanol contents 
solutions. The 70 % methanol fraction had the highest 
inhibitory activity. The fractions from Sephadex LH20 
column chromatography were analyzed by TLC 
developed with a chloroform methanol (9:1) mixture 
(Fig 2). The 70 % methanol fraction, was found to 
contain substance(s) with higher mobility.
Further purification of the 70 % methanol fraction of 
the 50 % aqueous acetone extract of Kaki calyx  
  The 70 % methanol fraction was further purified by 
si l ica gel column chromatography fol lowed by 
preparative thin layer chromatography. Finally, 
f r a c t i o n s f r om t h e p r e p a r a t i v e t h i n l a y e r 
chromatography, zone 1, 2 and 3 were obtained. Zhang 
et al reported that best resolution of oleanolic acid and 
ursolic acid was achieved using PAH
(polycyclic aromatic hydrocarbons) polymeric C18 
bonded phase column7. 
In addition to oleanolic acid and ursolic acid, betulinic 
acid was well separated by HPLC with a Zorbax 
Eclipse PAH column (Fig 3 a). It was found that 
betulinic acid was enriched in zone 2, as were oleanolic 
acid and ursolic acid in zone 3 (Fig 3 b, c) .
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The contents of zone 2 and zone 3 were analyzed by 
1H-NMR spectroscopy. The 1H-NMR signals of the 
main compound in zone 2 was identical with those of 
betulinic acid, while main compounds of zone 3 
werethought to be an equivalent mixture of oleanolis 
acid and ursolic acid. The inhibitory activity of the 
pure betulinic acid, oleanolic acid and ursolic acid, was 
tested (Fig 4). They all inhibited the activity more than 
50 % at a concentration of 100 ㎍ /ml. The IC ₅₀ of 
oleanolic acid and ursolic acid were ～20 ㎍ /ml, and 
betulinic acid ～60 ㎍ /ml. The IC ₅₀ of oleanolic acid and 
ursolic acid for HCV protease were similar to that 
reported by Ma et al reported, 26 and 16 ㎍ /ml, 
respectively₈ ₉. The triterpenes contained in the 50 % 
aqueous acetone extract of kaki calyx,betulinic acid, 
oleanolic acid and ursolic acid, were thought to be the 
main contributors of the inhibitory activity of the 
recombinant hepatitis C virus NS3/4A protease in the 
fractions eluted with greater than 70 % methanol. 
Ursolic acid and acetyl ursolic isolated from the stems 
of Cynomorium songaricum ₉, and oleanolic acid and 
its synthesized derivatives ₈ were reported to inhibit 
HCV protease. We found that betulinic acid also had 
inhibitory activity. Previously, betulinic acid was 
reported to be a potent inhibitor of eukaryotic 
topoisomerase I 10）, and selective inhibitor of human 
melanoma that functions by induction of apoptosis 11）. 
The triterpenes were found to be the main inhibitory 
ingredients in the 50 % aqueous acetone extract of kaki 
calyx on the enzyme, but there may be inhibitory 
compounds other than the triterpenes.  
Fig 1 Inhibitory activity and yield of extracts and fractions from Sephadex LH20 column chromatography
Fig 2 TLC of hexane extract and fractions from Sephadex LH20 column chromatography
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柿蔕エキスと含有トリテルペン成分の
組み替えHCV NS3/4Aタンパク質分解酵素阻害活性
垣内　信子，黒岩　大陸，土谷　和紀，渥美　聡孝，大塚　　功
九州保健福祉大学薬学部生薬学講座　〒882-8508　宮崎県延岡市吉野町1714-1
要旨
柿蔕のヘキサン、メタノール、50 % アセトン抽出物の、組み替え hepatitis C virus (HCV)の NS3/4A 蛋白
質分解酵素に対する阻害活性を検討した。50 % アセトン抽出物が最も阻害活性が強く、この抽出物を
Sephadex LH20カラムで分画を行なった。得た各画分のうち阻害活性の強かった 70 %メタノール画分を、
さらにシリカゲルカラム／薄層クロマトグラフィーで分画し、トリテルペンのベルリン酸、オレアノール酸、
ウルソール酸を分離した。これらのトリテルペンは polycyclic aromatic hydrocarbons (PAH) HPLC 
H-NMRスペクトルで同定した。これらトリテルペンは柿蔕の 50 %アセトン抽出物の主たる阻害物質と考え
られる。
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